Scholars Central

EditorialPublished 30 Nov 2024

Neoadjuvant vs Adjuvant Surgery in Cancer Management

Authors: Astrid Vestergaard

Cancer Surgery

Volume 9 · Issue 6 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Neoadjuvant and adjuvant therapies are essential components of modern cancer management. These approaches involve the use of chemotherapy, radiotherapy, or targeted therapy either before (neoadjuvant) or after (adjuvant) surgical resection to improve clinical outcomes. While both strategies aim to reduce the risk of recurrence and improve survival, they are employed in different clinical scenarios, depending on tumor type, stage, and patient characteristics. Neoadjuvant therapy aims to shrink tumors before surgery, facilitating less invasive resections and better surgical outcomes, while adjuvant therapy is administered after surgery to eliminate residual disease and prevent relapse. This article compares neoadjuvant and adjuvant approaches, highlighting the evidence supporting their use, key differences, and challenges associated with each. The goal is to provide a clearer understanding of the evolving role of these strategies in optimizing cancer treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Surgery.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Surgery
  • SubjectOncology & Cancer
  • SubjectSurgery
  • BylineArticles whose byline prints “Astrid Vestergaard”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels